Investors & Media

AIM Rule 26

Amryt Pharma’s strategy is to build a specialty pharmaceutical company focused on the development and commercialisation of drugs to treat rare and orphan diseases.

Admission Doc & Circulars

Elevator Pitch

Amryt Pharma Presentation

 

CEO Joe Wiley discusses the strategy to become a significant player in the orphan drug space and also talks through the Company presentation.

Biotech and Money Profile on Amryt Pharma.

Email Alerts

Subscribe to Our Newsletter:

Delivered by Investis – link to website (opens in a new window)